Non-Current Liabilities
Operating Lease Liabilities
West Pharmaceutical Services Operating Lease Liabilities decreased by 3.8% to $92.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.8%, from $78.80M to $92.00M. Over 5 years (FY 2020 to FY 2025), Operating Lease Liabilities shows an upward trend with a 9.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026
How to read this metric
An increase reflects long-term expansion of the leased asset base, while a decrease indicates a reduction in long-term lease commitments.
Detailed definition
This represents the portion of operating lease obligations that are due beyond the next twelve months. It reflects the l...
Peer comparison
Standard long-term liability for companies with significant real estate or equipment footprints.
Metric ID:
operating_lease_liabilities_non_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $56.00M | $53.40M | $63.00M | $68.90M | $70.20M | $77.20M | $93.00M | $89.90M | $87.30M | $83.00M | $84.50M | $82.40M | $84.60M | $82.30M | $81.80M | $78.80M | $79.80M | $73.50M | $95.60M | $92.00M |
| QoQ Change | — | -4.6% | +18.0% | +9.4% | +1.9% | +10.0% | +20.5% | -3.3% | -2.9% | -4.9% | +1.8% | -2.5% | +2.7% | -2.7% | -0.6% | -3.7% | +1.3% | -7.9% | +30.1% | -3.8% |
| YoY Change | — | — | — | — | +25.4% | +44.6% | +47.6% | +30.5% | +24.4% | +7.5% | -9.1% | -8.3% | -3.1% | -0.8% | -3.2% | -4.4% | -5.7% | -10.7% | +16.9% | +16.8% |
Range$53.40M – $95.60M
CAGR+11.0%
Avg YoY Growth+10.5%
Median YoY Growth+3.3%
Operating Lease Liabilities at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's operating lease liabilities?
- West Pharmaceutical Services (WST) reported operating lease liabilities of $92.00M in Q1 2026.
- How has West Pharmaceutical Services's operating lease liabilities changed year-over-year?
- West Pharmaceutical Services's operating lease liabilities increased by 16.8% year-over-year, from $78.80M to $92.00M.
- What is the long-term trend for West Pharmaceutical Services's operating lease liabilities?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's operating lease liabilities has grown at a 9.6% compound annual growth rate (CAGR), from $60.40M to $95.60M.
- What does operating lease liabilities mean?
- The amount of lease payments due after one year.